StoxTorrent Pharmaceuticals vs Mankind Pharma: share price & financials comparison
NSE: TORNTPHARM vs MANKIND · Healthcare · as of 13 Nov 2026
Both prices rebased to 100 at the start of the selected period.
Torrent Pharmaceuticals vs Mankind Pharma at a glance
Torrent Pharmaceuticals (TORNTPHARM) has a market capitalisation of ₹1,77,628 Cr, against ₹1,09,032 Cr for Mankind Pharma (MANKIND). Over the past year Torrent Pharmaceuticals has returned +30.6%, compared with +11.4% for Mankind Pharma. On valuation, Mankind Pharma trades at a lower P/E of 48.5 versus 83.6. Mankind Pharma earns a higher return on equity (12.8% vs 11.6%). Torrent Pharmaceuticals comes out ahead on size. Mankind Pharma comes out ahead on valuation, profitability, growth, financial health and technicals. Across the scored metrics below, Torrent Pharmaceuticals leads on 6 and Mankind Pharma on 10. On StoxGud's 10-point checklist, Torrent Pharmaceuticals scores 7/10 and Mankind Pharma scores 7/10.
| Metric | Torrent Pharmaceuticals | Mankind Pharma |
|---|---|---|
| Size | ||
| Market cap | ₹1,77,628 Cr | ₹1,09,032 Cr |
| Revenue (latest FY) | ₹13,980 Cr | ₹14,278 Cr |
| Net profit (latest FY) | ₹2,163 Cr | ₹1,913 Cr |
| Valuation | ||
| P/E | 83.6 | 48.5 |
| P/B | 9.67 | 6.20 |
| Dividend yield | 0.73% | 0.04% |
| Profitability | ||
| Return on equity | 11.6% | 12.8% |
| Net profit margin | 12.2% | 14.6% |
| Operating margin | 33.2% | 26.5% |
| Growth | ||
| Revenue growth (YoY) | +50.8% | +17.3% |
| Net profit growth (YoY) | -9.6% | +39.1% |
| Revenue CAGR (multi-year) | +11.8% | +17.7% |
| Financial health | ||
| Debt to equity | 0.76 | 0.31 |
| Momentum | ||
| 1-month return | +0.6% | +11.3% |
| 1-year return | +30.6% | +11.4% |
| 3-year CAGR | +31.2% | +12.9% |
| 5-year CAGR | +27.3% | — |
| 10-year CAGR | +22.2% | — |
| Distance from 52W high | -8.8% | -1.1% |
| Technicals | ||
| RSI (14) | 62 | 84 |
| Price vs 200-day avg | +2.8% | +13.3% |
Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.
10-point checklist side by side
| Check | Torrent Pharmaceuticals | Mankind Pharma |
|---|---|---|
| Price above 50-day average | ✗ | ✓ |
| Price above 200-day average | ✓ | ✓ |
| 50-day average above 200-day (uptrend) | ✓ | ✓ |
| RSI in healthy 40–70 zone | ✓ | ✗ |
| Positive 1-year return | ✓ | ✓ |
| Return on equity above 15% | ✗ | ✗ |
| Debt to equity below 1 | ✓ | ✓ |
| Revenue growing year on year | ✓ | ✓ |
| Net profit margin above 10% | ✓ | ✓ |
| P/E below industry median | ✗ | ✗ |
| Score | 7/10 | 7/10 |
A rules-based screen for education only — not a buy or sell recommendation.
FAQs
Which is bigger, Torrent Pharmaceuticals or Mankind Pharma?
Torrent Pharmaceuticals has a market cap of ₹1,77,628 Cr and Mankind Pharma has a market cap of ₹1,09,032 Cr as of 13 Nov 2026.
Which has a lower P/E, Torrent Pharmaceuticals or Mankind Pharma?
Mankind Pharma has the lower P/E: Torrent Pharmaceuticals trades at 83.6 and Mankind Pharma at 48.5.
Which gave better returns in the last year, Torrent Pharmaceuticals or Mankind Pharma?
Torrent Pharmaceuticals did better: Torrent Pharmaceuticals returned +30.6% and Mankind Pharma returned +11.4% over one year.
What is the difference between Torrent Pharmaceuticals and Mankind Pharma?
Both are NSE-listed companies in Healthcare. Torrent Pharmaceuticals is about 1.6 times the size of Mankind Pharma by market cap. In the latest financial year Torrent Pharmaceuticals reported revenue of ₹13,980 Cr and Mankind Pharma ₹14,278 Cr. Operating margin is 33.2% for Torrent Pharmaceuticals and 26.5% for Mankind Pharma. Debt to equity is 0.76 for Torrent Pharmaceuticals and 0.31 for Mankind Pharma.
Which is better, Torrent Pharmaceuticals or Mankind Pharma?
It depends on what you are looking for, and StoxGud does not recommend either stock. On the metrics compared above, Torrent Pharmaceuticals leads on 6 and Mankind Pharma on 10. Torrent Pharmaceuticals is ahead on size. Mankind Pharma is ahead on valuation, profitability, growth, financial health and technicals. On StoxGud's rules-based checklist Torrent Pharmaceuticals scores 7/10 and Mankind Pharma scores 7/10. This is information, not advice: consult a SEBI-registered adviser before investing.